Pure Global AI
NCT06377007Recruiting

Refractive Outcomes and Ocular Biometry of Two Swept-Source Optical Coherence Tomography-Based Biometers With Segmental or Equivalent Refractive Indices (ORION)

Refractive Outcomes and Ocular Biometry of Two Swept-Source Optical Coherence Tomography-Based Biometers With Segmental or Equivalent Refractive Indices (ORION): A Non-Inferiority Randomized Clinical Trials
Walailak UniversityClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Cataract
Drug/Device/Intervention
IOLMaster 700 (Carl Zeiss Meditec AG)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Walailak University
Location
Nakhon Si Thammarat, Thailand
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Dec 30, 2025
Enrollment
142 participants
Primary outcome

Mean absolute prediction error

Summary

Cataract surgery represents a common surgical intervention, encompassing the extraction of
 the opaque natural crystalline lens, followed by the substitution with an artificial
 intraocular lens (IOL). To ascertain an IOL possessing optimal power, antecedent to the
 surgery, preoperative evaluations are conducted through the utilization of a biometric
 devices. Diverse categories of these instruments are accessible, each harnessing distinct
 optical methodologies or mathematical algorithms to ascertain the most fitting IOL power. The
 principal objective of this study was to evaluate the ocular biometry and the predictive
 precision outcome of a biometer that uses standard keratometry to the prediction accuracy of
 another biometer that uses Total Keratometry.

ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06377007
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06377007 through Pure Global AI's free database. This phase not specified trial is sponsored by Walailak University and is currently Recruiting. The study focuses on Cataract. Target enrollment is 142 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.